Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis of the Literature

Study Questions:

What is the clinical benefit of novel oral anticoagulants (NOACs) compared with vitamin K antagonists for the prevention of stroke or systemic embolism in patients with atrial fibrillation?